FILTER
FILTERED INTERVIEW RESULTS
Alan Rubino
CEO, EMISPHERE TECHNOLOGIES
Emisphere Technologies is a leading company in converting injectable therapeutics into advanced oral formulations.
Stephen Wang & Ryan Yoder
CHAIRMAN and CEO & VP BUSINESS DEVELOPMENT, KINGCHEM LIFE SCIENCE
Kingchem provides contract development and manufacturing services to the pharmaceutical and chemical industries.
Karen Fallen
SENIOR VICE PRESIDENT: BUSINESS UNIT HEAD - CLINICAL DEVELOPMENT & MANUFACTURING, LONZA
Lonza is one of the world's leading suppliers to the pharma, biotech and specialty ingredient markets.
Shabbir Dahod
PRESIDENT AND CEO, TRACELINK
TraceLink is the world’s largest integrated digital supply network connecting the life sciences supply chain.
Christiana Goh Bardon
MD, MBA, MANAGING DIRECTOR, UBS ONCOLOGY IMPACT FUND MANAGED BY MPM CAPITAL & PORTFOLIO MANAGER, BURRAGE CAPITAL FUND
UBS Oncology Impact Fund is an evergreen fund specializing in investments in early stage oncology and cancer therapeutics.
Geoff Meyerson
CEO AND CO-FOUNDER, LOCUST WALK
Locust Walk is a global life science transaction firm with an integrated team-based approach across capabilities, geographies, and industry segments to deliver the right products, the right partners, and the most attractive sources of capital to get the right deals done for biopharma and medtech companies.
Jonathan Retano
FOUNDER AND CEO, PHARMAFUSION
Pharmafusion provides data warehouse and business analytics solutions for the pharmaceutical industry.
John Patrick Oroho
EXECUTIVE VICE PRESIDENT AND CHIEF STRATEGY OFFICER AT PORZIO LIFE SCIENCES
Porzio Life Sciences is dedicated to helping pharmaceutical, medical device and biotechnology organizations master the evolving regulatory environment.
Paul Hennessey
SENIOR VP SALES, CONTRACT PHARMACAL CORP. (CPC)
Contract Pharmacal Corp. manufactures and packages pharmaceuticals, over-the-counter drugs and dietary supplements.
Robert K. Coughlin
PRESIDENT & CEO, MASSBIO
MassBio’s mission is to advance Massachusetts' leadership in life sciences to grow the industry, add value to the healthcare system and improve patient lives.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2024 - Digital Interactive
"Cautious optimism. These two words best describe the state of mind of life sciences executives as we enter the second half of 2024. "
"Cautious optimism. These two words best describe the state of mind of life sciences executives as we enter the second half of 2024. "
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
